Back

Impact and cost-effectiveness of nonavalent human papillomavirus vaccination in Switzerland: insights from a dynamic transmission model

2019-12-11 health economics Title + abstract only
View on medRxiv
Show abstract

AIMIn Switzerland, human papillomavirus (HPV) vaccination has been implemented using a quadrivalent vaccine that covers HPV types 16 and 18, responsible for about 70% of cervical cancer. The average national uptake was 56% in girls by the age of 16 years in 2014-2016. A nonavalent vaccine, covering five additional oncogenic HPV types was recommended at the end of 2018. The primary aim of this study was to assess the impact and cost-effectiveness of introducing the nonavalent HPV vaccine in Switz...

Predicted journal destinations

1
eLife
262 training papers
#1 24.3%
2
PLOS ONE
1737 training papers
Top 52% 12.0%
3
BMC Medicine
155 training papers
Top 0.3% 8.5%
4
BMJ Open
553 training papers
Top 22% 7.0%
5
Vaccine
140 training papers
Top 2% 5.5%
6
PLOS Medicine
95 training papers
Top 1% 4.2%
7
BMC Health Services Research
43 training papers
Top 2% 2.1%
8
BMC Public Health
148 training papers
Top 14% 2.1%
9
Vaccines
131 training papers
Top 4% 2.1%
10
Proceedings of the National Academy of Sciences
100 training papers
Top 4% 2.1%
11
Scientific Reports
701 training papers
Top 78% 2.1%
12
Nature Communications
483 training papers
Top 41% 1.7%
13
BMJ Global Health
95 training papers
Top 11% 1.7%
14
Clinical Infectious Diseases
219 training papers
Top 18% 1.5%
15
PLOS Neglected Tropical Diseases
166 training papers
Top 12% 1.5%
16
PLOS Global Public Health
287 training papers
Top 24% 1.5%
17
Journal of Medical Internet Research
81 training papers
Top 15% 1.0%
18
eClinicalMedicine
55 training papers
Top 5% 0.8%
19
British Journal of Cancer
22 training papers
Top 5% 0.8%
20
The Lancet Infectious Diseases
57 training papers
Top 8% 0.8%
21
JAMA Network Open
125 training papers
Top 28% 0.8%
22
Frontiers in Public Health
135 training papers
Top 37% 0.5%
23
The Lancet Global Health
24 training papers
Top 3% 0.5%
24
Frontiers in Medicine
99 training papers
Top 30% 0.5%
25
Vaccine: X
16 training papers
Top 0.5% 0.5%
26
Genetics in Medicine
57 training papers
Top 7% 0.5%